RNASET2, GPR174, and PTPN22 gene polymorphisms are related to the risk of liver damage associated with the hyperthyroidism in patients with Graves' disease. Issue 2 (31st May 2017)

• Record Type: Journal Article
• Authors: Zhang, Qing; Liu, Shaozheng; Guan, Yanxing; Chen, Qingjie; Zhang, Qing; Min, Xiang
• Is Part Of: Journal of clinical laboratory analysis. Volume 32:Issue 2(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-05-31
• Subjects: gene polymorphism -- GPR174 -- liver damage -- PTPN22 -- RNASET2; Diagnosis, Laboratory -- Periodicals; Medical laboratory technology -- Periodicals; 616
• DOI: 10.1002/jcla.22258
• Languages: English
• ISSNs: 0887-8013

Abstract

Abstract : Objectives: This study was designed to unveil the association of GPR174 rs3827440, PTPN22 rs3789604, and RNASET2 rs9355610 with the onset of liver damage (LD) among the Graves' disease (GD) patients. Methods: A total of 120 GD patients were divided into the none‐LD and LD groups. Several indicators were detected for assessing liver functions, and genotypes of single nucleotide polymorphisms (SNPs) were identified. Logistic regression was introduced for investigating the relationship between risk SNPs and LD‐associated hyperthyroidism in GD patients. Results: Significant differences were identified between LD and none‐LD groups regarding genotype distributions of rs3827440, rs3789604, and rs9355610. Results from logistic regression indicted that among the GD patients, C carriers of PTPN22 rs3789604 were associated with a higher risk of LD‐associated hyperthyroidism, while C carriers of rs3827440 ( GPR174 ) and G carriers of rs9355610 ( RNASET2) were associated with a reduced risk of LD‐associated hyperthyroidism. Conclusions: The C allele of rs3789604 ( PTPN22 ) was a significant risk factor for LD‐associated hyperthyroidism in GD patients, whereas C allele of GPR174 rs3827440 and G allele of RNASET2 rs9355610 appeared to be a protective factor for this disease.